List of Excipients in API fluocinolone acetonide, hydroquinone, and tretinoin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing fluocinolone acetonide, hydroquinone, and tretinoin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Galderma Laboratories LP | TRI-LUMA | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 | ANHYDROUS CITRIC ACID | 1969-12-31 |
| Galderma Laboratories LP | TRI-LUMA | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 | BUTYLATED HYDROXYTOLUENE | 1969-12-31 |
| Galderma Laboratories LP | TRI-LUMA | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 | CETYL ALCOHOL | 1969-12-31 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for fluocinolone acetonide, hydroquinone, and tretinoin
Excipient focus: ANHYDROUS CITRIC ACID
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM ALUMINUM SILICATE
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL GLUCETH-10
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing METHYL GLUCETH-10
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing METHYL GLUCETH-10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-100 STEARATE
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing PEG-100 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing PEG-100 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
fluocinolone acetonide, hydroquinone, and tretinoin drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Galderma Laboratories LP | fluocinolone acetonide, hydroquinone, and tretinoin | 0299-5950 |
| >Company | >Ingredient | >NDC |
fluocinolone acetonide, hydroquinone, and tretinoin drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links